| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Dishman Carbogen Amcis Limited (NSE: DCAL)
DCAL Technical Analysis
1.5
| As on 19th Apr 2024 DCAL SHARE Price closed @ 221.05 and we RECOMMEND Buy for LONG-TERM with Stoploss of 171.72 & Sell for SHORT-TERM with Stoploss of 226.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DCALSHARE Price
| Open | 217.00 | Change | Price | % |
| High | 224.15 | 1 Day | 1.50 | 0.68 |
| Low | 213.40 | 1 Week | -13.90 | -5.92 |
| Close | 221.05 | 1 Month | 2.65 | 1.21 |
| Volume | 383540 | 1 Year | 86.60 | 64.41 |
| 52 Week High 195.10 | 52 Week Low 82.10 | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.90 | -2.27% |
| YESBANK | 23.95 | 0.21% |
| GTLINFRA | 1.75 | 0.00% |
| NHPC | 87.15 | -2.63% |
| TATASTEEL | 162.10 | 1.28% |
| SUZLON | 39.35 | -4.37% |
| INDUSTOWER | 351.40 | 2.03% |
| PNB | 128.25 | -1.00% |
| SAIL | 146.05 | 0.86% |
| ZOMATO | 189.20 | 2.16% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| EXCEL | 0.50 | -9.09% |
| ANMOL | 42.25 | -7.85% |
| SHARDAMOTR | 1504.15 | -5.41% |
| TATACOMM | 1755.20 | -5.33% |
| JUBLPHARMA | 665.00 | -5.09% |
| ARENTERP | 52.10 | -5.01% |
| PVP | 31.30 | -5.01% |
| PVP | 31.30 | -5.01% |
| ARVEE | 237.35 | -5.00% |
| GKWLIMITED | 2531.05 | -5.00% |
| DCAL Daily Charts |
DCAL Intraday Charts |
Whats New @ Bazaartrend |
DCAL Free Analysis |
|
|
DCAL Important Levels Intraday
| RESISTANCE | 241.77 |
| RESISTANCE | 235.12 |
| RESISTANCE | 231.02 |
| RESISTANCE | 226.91 |
| SUPPORT | 215.19 |
| SUPPORT | 211.08 |
| SUPPORT | 206.98 |
| SUPPORT | 200.33 |
DCAL Target April 2024
| 4th UP Target | 442.42 |
| 3rd UP Target | 382.91 |
| 2nd UP Target | 346.12 |
| 1st UP Target | 309.33 |
| 1st DOWN Target | 204.37 |
| 2nd DOWN Target | 167.58 |
| 3rd DOWN Target | 130.79 |
| 4th DOWN Target | 71.28 |
DCAL Weekly Target
| 4th UP Target | 275.13 |
| 3rd UP Target | 262.24 |
| 2nd UP Target | 254.28 |
| 1st UP Target | 246.31 |
| 1st DOWN Target | 223.59 |
| 2nd DOWN Target | 215.62 |
| 3rd DOWN Target | 207.66 |
| 4th DOWN Target | 194.77 |
DCAL Target2024
| 4th UP Target | 367.12 |
| 3rd UP Target | 304.21 |
| 2nd UP Target | 265.32 |
| 1st UP Target | 226.43 |
| 1st DOWN Target | 115.47 |
| 2nd DOWN Target | 76.58 |
| 3rd DOWN Target | 37.69 |
| 4th DOWN Target | -25.22 |
Dishman Carbogen Amcis Limited ( NSE INDIA Symbol : DCAL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DCAL Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 70.00 | |
| 10 Day Avg Volume | Traded 11.37 % More then 10 Day Average Volume | ||
DCAL Other Details
| Segment | EQ | |
| Market Capital | 34507939840.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > | |
DCAL Address
 |
||
DCAL Latest News
DCAL Business Profile
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP. Address: Dishman Corporate House, Ahmedabad, India, 380058
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service